Abstract
Abstract
Background: Chronic renal failure (CRF) is characterized by a great loss in renal function ending with reduced sodium filtration and suppression of tubular reabsorption that eventually leads to volume expansion. The objective of this study was to evaluate the possible renopreventive effects of NLRP3 inflammasome inhibitor MCC950 in adenine-induced CRF in rats.
Results: Results showed that the NLRP3 inflammasome inhibitor MCC950 had a renopreventive effect that was established by a decrease in blood pressure measurements, and improvement of urinary, serum, and renal tissue markers as revealing organ damage. This was also revealed by the reduction of tubular expression of neutrophil gelatinase-associated lipocalin (NGAL).
Immunohistochemical studies revealed that the worsened renal cellular changes indicated by raised expression of caspase-3 and IL-1β were prominently improved by NLRP3 inflammasome inhibitor MCC950 administration.
Conclusion: The NLRP3 inflammasome inhibitor MCC950 administration in the CRF rat model had renopreventive effects which may be a potential therapeutic approach to prevent the progression of CRF.
Publisher
Research Square Platform LLC
Reference70 articles.
1. Chronic Kidney Disease Diagnosis and Management: A Review;Chen TK;JAMA,2019
2. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association;Rangaswami J;Circulation,2019
3. Quercetin alleviates chronic renal failure by targeting the PI3k/Akt pathway;Tu H;Bioengineered,2021
4. Aseneh JB, Kemah B-LA, Mabouna S, Njang ME, Ekane DSM, Agbor VNJBn. Chronic kidney disease in Cameroon: a scoping review. 2020;21(1):1–11.
5. Gyurászová M, Gurecká R, Bábíčková J. Tóthová ĽJOm, longevity c. Oxidative stress in the pathophysiology of kidney disease: implications for noninvasive monitoring and identification of biomarkers. 2020;2020.